CanBas Co., Ltd.

¥666.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4575Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 0.57%
Div yield —
ROE (57.07%)
Biotechnology
Beta (5Y) (0.89)
PE TTM —
TSR TTM (23.71%)
Mkt cap ¥13.17B
ROIC (37.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥684
2.76%
(40.11%)
Hold 4|7|1|8|2
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
11.84
12.89
12.77
12.79
17.06%
15.00%
12.46%
5.85%
Revenue¥B
0.932
0.945
0.995
1.006
2.84%
6.91%
15.57%
12.41%
Peers (US$83.60M)
Cap (US$)
PE
94.71M
90.59x
Capital
TTM
5Y
10Y
Leveragex
0.357
0.251
0.222
EBIT/Intx
0.371
0.093
0.104
Own earn%
235.86
22.13
25.80
Sh yield%
25.25
41.85
41.90
Owners
Insiders/Inst%
5.74
21.89
Short interest%
3.91
SBC / revenue%
1.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
18–24
$1 testx
0.0
Incr. ROIC%
50